hematologic neoplasms

TIGIT blockade repolarizes AML-associated TIGIT⁺ M2 macrophages to an M1 phenotype and increases CD47-mediated phagocytosis
Franziska Brauneck, Brit Fischer, Marius Witt, Jana Muschhammer, Jennyfer Oelrich, Pedro Henrique da Costa Avelar, Sophia Tsoka, Lars Bullinger, Elisa Seubert, Daniel J Smit, Carsten Bokemeyer, Christin Ackermann, Jasmin Wellbrock, Friedrich Haag, Walter Fiedler

Journal for ImmunoTherapy of Cancer Dec 2022, 10 (12) e004794; DOI: 10.1136/jitc-2022-004794
MYC/BCL2/BCL6 triple hit and TP53 deletion in a case of high-grade B cell lymphoma receiving CAR T cell immunotherapy
Jiachen Wang, Zhen Shang, Jue Wang, Jinhuan Xu, Weigang Li, Yuqi Guan, Li Yang, Wei Zhang, Kefeng Shen, Meilan Zhang, Jin Wang, Liting Chen, Qinlu Li, Cheng He, Na Wang, Liang Huang, Yi Xiao, Min Xiao, Jianfeng Zhou

Journal for ImmunoTherapy of Cancer Jun 2021, 9 (6) e002029; DOI: 10.1136/jitc-2020-002029
Role of peripheral blood MRD and 18F-FDG PET in the post-CAR relapse setting: a case study of discordant peripheral blood and bone marrow MRD
Liora Schultz, Kara Lynn Davis, Ann Walkush, Christina Baggott, Courtney Erickson, Sneha Ramakrishna, Catherine Aftandilian, Norman Lacayo, Helen Ruth Nadel, Jean Oak, Crystal L Mackall

Journal for ImmunoTherapy of Cancer Feb 2023, 11 (2) e004851; DOI: 10.1136/jitc-2022-004851
Venetoclax improves CD20 immunotherapy in a mouse model of MYC/BCL2 double-expressor diffuse large B-cell lymphoma
Javier Melchor, Marcos Garcia-Lacarte, Sara C. Grijalba, Adrián Arnaiz-Leché, Marién Pascual, Carlos Panizo, Oscar Blanco, Victor Segura, Francisco J. Novo, Juan Garcia Valero, Patricia Pérez-Galán, Jose A. Martinez-Climent, Sergio Roa

Journal for ImmunoTherapy of Cancer Feb 2023, 11 (2) e006113; DOI: 10.1136/jitc-2022-006113
Safety and efficacy of autologous and allogeneic humanized CD19-targeted CAR-T cell therapy for patients with relapsed/refractory B-ALL
Fengmei Song, Yongxian Hu, Yanlei Zhang, Mingming Zhang, Tingting Yang, Wenjun Wu, Simao Huang, Huijun Xu, Alex H Chang, He Huang, Guoqing Wei

Journal for ImmunoTherapy of Cancer Feb 2023, 11 (2) e005701; DOI: 10.1136/jitc-2022-005701
Helicobacter pylori infection disturbs the tumor immune microenvironment and is associated with a discrepant prognosis in gastric de novo diffuse large B-cell lymphoma
Yuwei Deng, Wenjia Su, Junwen Zhu, Hongfei Ji, Xiaoping Zhou, Jingshu Geng, Jiayu Zhu, Qingyuan Zhang

Journal for ImmunoTherapy of Cancer Oct 2021, 9 (10) e002947; DOI: 10.1136/jitc-2021-002947
Humoral immunogenicity of the seasonal influenza vaccine before and after CAR-T-cell therapy: a prospective observational study
Carla S Walti, Andrea N Loes, Kiel Shuey, Elizabeth M Krantz, Jim Boonyaratanakornkit, Jacob Keane-Candib, Tillie Loeffelholz, Caitlin R Wolf, Justin J Taylor, Rebecca A Gardner, Damian J Green, Andrew J Cowan, David G Maloney, Cameron J Turtle, Steven A Pergam, Helen Y Chu, Jesse D Bloom, Joshua A Hill

Journal for ImmunoTherapy of Cancer Oct 2021, 9 (10) e003428; DOI: 10.1136/jitc-2021-003428
JAK inhibitors and COVID-19
Gabriel Levy, Paola Guglielmelli, Peter Langmuir, Stefan N Constantinescu

Journal for ImmunoTherapy of Cancer Apr 2022, 10 (4) e002838; DOI: 10.1136/jitc-2021-002838
Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia
Daniele Caracciolo, Caterina Riillo, Andrea Ballerini, Giuseppe Gaipa, Ludovic Lhermitte, Marco Rossi, Cirino Botta, Eugénie Duroyon, Katia Grillone, Maria Eugenia Gallo Cantafio, Chiara Buracchi, Greta Alampi, Alessandro Gulino, Beatrice Belmonte, Francesco Conforti, Gaetanina Golino, Giada Juli, Emanuela Altomare, Nicoletta Polerà, Francesca Scionti, Mariamena Arbitrio, Michelangelo Iannone, Massimo Martino, Pierpaolo Correale, Gabriella Talarico, Andrea Ghelli Luserna di Rorà, Anna Ferrari, Daniela Concolino, Simona Sestito, Licia Pensabene, Antonio Giordano, Markus Hildinger, Maria Teresa Di Martino, Giovanni Martinelli, Claudio Tripodo, Vahid Asnafi, Andrea Biondi, Pierosandro Tagliaferri, Pierfrancesco Tassone

Journal for ImmunoTherapy of Cancer Feb 2021, 9 (2) e002026; DOI: 10.1136/jitc-2020-002026
Use of pembrolizumab with or without pomalidomide in HIV-associated non-Hodgkin’s lymphoma
Kathryn Lurain, Ramya Ramaswami, Ralph Mangusan, Anaida Widell, Irene Ekwede, Jomy George, Richard Ambinder, Martin Cheever, James L Gulley, Priscila H Goncalves, Hao-Wei Wang, Thomas S Uldrick, Robert Yarchoan

Journal for ImmunoTherapy of Cancer Feb 2021, 9 (2) e002097; DOI: 10.1136/jitc-2020-002097

Main menu

hematologic neoplasms

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

hematologic neoplasms

Pages